Arterra Bioscience Income Statement

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	4.65	4.17	3.3	3.56	3.83
Other Revenue	0.06	0	0.03	0.03	0.92
Revenue	4.7	4.17	3.34	3.59	4.74
Revenue Growth (YoY)	12.74%	25.08%	-7.10%	-24.27%	13.64%
Cost of Revenue	1.77	1.76	1.49	1.15	1.44
Gross Profit	2.94	2.41	1.85	2.44	3.3
Selling, General & Admin	1.94	1.69	1.56	1.47	1.39
Amortization of Goodwill & Intangibles	0.01	0.03	0.18	0.18	0.19
Other Operating Expenses	-1.22	-0.99	-1.3	-1.16	0.18
Operating Expenses	1.01	1.04	0.79	0.84	2.06
Operating Income	1.93	1.37	1.06	1.6	1.25
Interest Expense	-0	-0	-0.01	-0.01	-0.01
Interest & Investment Income	0.2	0.2	0.16	0.2	-
Earnings From Equity Investments	-	-	-	-	0
Other Non Operating Income (Expenses)	-	0.13	0.09	0	0.03
EBT Excluding Unusual Items	2.13	1.7	1.3	1.8	1.27
Asset Writedown	-0.13	-	-	-	-
Pretax Income	2	1.7	1.3	1.8	1.27
Income Tax Expense	-0.01	0.36	0.23	0.38	0.16
Net Income	2.01	1.34	1.08	1.41	1.11
Net Income to Common	2.01	1.34	1.08	1.41	1.11
Net Income Growth	50.09%	24.21%	-23.89%	27.33%	0.18%
Shares Outstanding (Basic)	7	7	7	-	-
Shares Outstanding (Diluted)	7	7	7	-	-
EPS (Basic)	0.30	0.20	0.16	-	-
EPS (Diluted)	0.30	0.20	0.16	-	-
EPS Growth	50.09%	24.21%	-	-	-
Free Cash Flow	1.54	0.42	0.96	1.3	0.86
Free Cash Flow Per Share	0.23	0.06	0.14	-	-
Dividend Per Share	-	0.130	0.100	0.100	0.050
Dividend Growth	-	30.00%	-	100.00%	-
Gross Margin	62.44%	57.85%	55.46%	68.03%	69.69%
Operating Margin	41.06%	32.90%	31.75%	44.57%	26.32%
Profit Margin	42.64%	32.03%	32.26%	39.38%	23.42%
Free Cash Flow Margin	32.71%	10.15%	28.77%	36.23%	18.05%
EBITDA	2.22	1.71	1.59	2.13	1.74
EBITDA Margin	47.22%	41.03%	47.70%	59.38%	36.60%
D&A For EBITDA	0.29	0.34	0.53	0.53	0.49
EBIT	1.93	1.37	1.06	1.6	1.25
EBIT Margin	41.06%	32.90%	31.75%	44.57%	26.32%
Effective Tax Rate	-	21.44%	17.36%	21.33%	12.83%
Revenue as Reported	6.12	5.27	4.95	5.3	4.61

Source: S&P Global Market Intelligence. Standard template. Financial Sources.